Hippo Signaling Pathway
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".
Deadline for manuscript submissions: closed (30 April 2016) | Viewed by 61304
Special Issue Editor
Special Issue Information
Dear Colleagues,
The Salvador/Warts/Hippo (Hippo) signaling pathway has emerged in the last two decades as a tumor suppressor kinase cascade that regulates cell growth and organ size. Rapid progress has been made by connecting four seemingly disparate areas of research: 1) discovery by genetic screens in Drosophila of initial pathway kinases and scaffolding proteins and more recently new pathway components, 2) TEAD (TEA domain) transcription factors and their associated transcriptional coactivators YAP and TAZ, controlled by the Hippo pathway kinases mainly through YAP/TAZ phosphorylation, 3) studies in transgenic mice and other mammalian cells and 4) studies of human disease pathology. Hippo signaling is now seen as an increasingly complex signaling network that cross-talks with many other signaling pathways and is implicated in mechanotransduction, stem cells, tissue regeneration and cancer progression. Our increased understanding holds the promise of identifying new targets for cancer treatment.
This open access Special Issue provides an opportunity to review the different experimental strands that have contributed to our understanding of Hippo signaling. We also hope to include a broad range of current work, and welcome significant contributions of all kinds.
Dr. Paul A. Reynolds
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Hippo pathway
- YAP/TAZ
- TEADs
- polarity
- GPCR
- organ size
- actin cytoskeleton
- phosphorylation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.